
DSCSA verifies package movement, but resilience requires visibility into capacity, quality and sourcing risk.
Vishal Chakravarty is founder and chief executive officer of NovaPharm Healthcare Ltd.

DSCSA verifies package movement, but resilience requires visibility into capacity, quality and sourcing risk.

Domestic manufacturing can reduce certain dependencies, but reliable pharmaceutical commercialization requires qualified redundancy, sustainable economics, quality maturity and decision-ready visibility across the full supply network.